{
  "directed": true,
  "graph": {
    "annotation_list": {
      "Dose": [
        "80 nM"
      ],
      "Extract_type": [
        "Lipid"
      ],
      "Protein_tag": [
        "FLAG-Sac1"
      ],
      "PublicationStatus": [
        "Published"
      ],
      "PublicationType": [
        "Research"
      ],
      "Section": [
        "Results"
      ]
    },
    "annotation_pattern": {
      "BioAssay": ".*"
    },
    "annotation_url": {
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20190128.belanno",
      "Species": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/species-taxonomy-id/species-taxonomy-id-20170511.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Priya S",
      "contact": "priya@causalitybiomodels.com",
      "copyright": "Copyright Â© 2020 Fraunhofer Institute SCAI, All rights reserved",
      "description": "COVID Knowledge Curation project",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "name": "22253445.bel",
      "version": "2.1.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$",
      "UNIPROT": "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\\.\\d+)?$"
    },
    "namespace_url": {
      "CHEBI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
      "GO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns",
      "MESH": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
      "TAX": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns"
    },
    "path": "22253445.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "We found that LY294002 (PI kinase inhibitor) significantly inhibited the entry of SARS pseudovirions into VeroE6 cells, whereas entry of VSV-G pseudovirus was not affected (Fig. 1A).",
      "key": "086e14ab34e445fdb7d243767b20f998",
      "line": 55,
      "relation": "decreases",
      "source": 3,
      "target": 12
    },
    {
      "key": "f591678a16da6709c4b6d115edbeaf66",
      "relation": "partOf",
      "source": 3,
      "target": 6
    },
    {
      "annotations": {
        "BioAssay": {
          "immunoassay": true
        },
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "Immunostaining with an anti-PI4P monoclonal antibody revealed the enrichment of PI4P within the cytoplasm of normal cells (Fig. 4A, left panel). However, most PI4P immunofluorescence was lost after a 30-min treatment with LY294002 (Fig. 4A, right panel).",
      "key": "29dedbd5641d1407927292f1a925cf83",
      "line": 109,
      "object": {
        "location": {
          "name": "cytoplasm",
          "namespace": "GO"
        }
      },
      "relation": "decreases",
      "source": 3,
      "target": 0
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "c8a4e2b3f4a32b6db5387606b362cfda",
      "line": 127,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 3,
      "target": 11
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "4c6ce58e1072d3a0ce3871a460495a41",
      "line": 130,
      "relation": "decreases",
      "source": 3,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "We found that LY294002 (PI kinase inhibitor) significantly inhibited the entry of SARS pseudovirions into VeroE6 cells, whereas entry of VSV-G pseudovirus was not affected (Fig. 1A).",
      "key": "9df86b9c0c8c0cf2838b6e19d2a86329",
      "line": 57,
      "relation": "association",
      "source": 12,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "Another PI kinase inhibitor, wortmannin, also inhibited SARS-CoV S-mediated entry into VeroE6 cells with no effect on VSV-G pseudovirus entry (Fig. 1E).",
      "key": "29d9aa036d08645d03aafa3161034940",
      "line": 64,
      "relation": "association",
      "source": 12,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Dose": {
          "80 nM": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "From these results, we conclude that LY294002 and wortmannin inhibit SARS pseudovirus entry by targeting PI4KB and that PI4KB is involved in SARS-CoV S-mediated entry into VeroE6 cells.",
      "key": "a0ef4c47c906387e593bbb3259ef10c3",
      "line": 82,
      "relation": "association",
      "source": 12,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Dose": {
          "80 nM": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "From these results, we conclude that LY294002 and wortmannin inhibit SARS pseudovirus entry by targeting PI4KB and that PI4KB is involved in SARS-CoV S-mediated entry into VeroE6 cells.",
      "key": "3622a7710d61690483adfe08120a1646",
      "line": 80,
      "relation": "positiveCorrelation",
      "source": 12,
      "target": 11
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "We found that LY294002 (PI kinase inhibitor) significantly inhibited the entry of SARS pseudovirions into VeroE6 cells, whereas entry of VSV-G pseudovirus was not affected (Fig. 1A).",
      "key": "1d2859f58d87e622c1147c487c62778c",
      "line": 57,
      "relation": "association",
      "source": 4,
      "target": 12
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "Another PI kinase inhibitor, wortmannin, also inhibited SARS-CoV S-mediated entry into VeroE6 cells with no effect on VSV-G pseudovirus entry (Fig. 1E).",
      "key": "7518a599d4f9c7249d20ff4df932aff4",
      "line": 64,
      "relation": "association",
      "source": 4,
      "target": 12
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Dose": {
          "80 nM": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "From these results, we conclude that LY294002 and wortmannin inhibit SARS pseudovirus entry by targeting PI4KB and that PI4KB is involved in SARS-CoV S-mediated entry into VeroE6 cells.",
      "key": "fadd61228dcd3b129607b2652a6814cd",
      "line": 82,
      "relation": "association",
      "source": 4,
      "target": 12
    },
    {
      "key": "a0b86dd6e793234be841daccde448f77",
      "relation": "partOf",
      "source": 4,
      "target": 7
    },
    {
      "key": "d2f2f10ee074d183113dfeeb693bd48f",
      "relation": "partOf",
      "source": 4,
      "target": 8
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "Another PI kinase inhibitor, wortmannin, also inhibited SARS-CoV S-mediated entry into VeroE6 cells with no effect on VSV-G pseudovirus entry (Fig. 1E).",
      "key": "ee10a5fd432744a8d70225e907ac15fb",
      "line": 63,
      "relation": "decreases",
      "source": 1,
      "target": 12
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Dose": {
          "80 nM": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "We found that entry of SARS pseudovirions into VeroE6 cells was inhibited by wortmannin with an IC50 of 80 nM (Fig. 1F), which was consistent with the results reported for type III PI4Ks (PI4KA and PI4KB) (22, 23).",
      "key": "9833c5847ed043f6a7e20c5fe34ccc55",
      "line": 72,
      "relation": "decreases",
      "source": 1,
      "target": 12
    },
    {
      "key": "9cc56e39eb9dcc8a27f42db6e5f27f6d",
      "relation": "partOf",
      "source": 1,
      "target": 5
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "bac26600606cfd20a2dc1c008bb367a4",
      "line": 128,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 1,
      "target": 11
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "10abca9a6794010c2558cfb512c45365",
      "line": 131,
      "relation": "decreases",
      "source": 1,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Dose": {
          "80 nM": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "From these results, we conclude that LY294002 and wortmannin inhibit SARS pseudovirus entry by targeting PI4KB and that PI4KB is involved in SARS-CoV S-mediated entry into VeroE6 cells.",
      "key": "bf9fe7603330826dc7aa39b03a2973a7",
      "line": 80,
      "relation": "positiveCorrelation",
      "source": 11,
      "target": 12
    },
    {
      "key": "9c818037473f18f40f9b0976e1d3279c",
      "relation": "partOf",
      "source": 11,
      "target": 6
    },
    {
      "key": "2e578d766284dd1d1ea538d45caa362b",
      "relation": "partOf",
      "source": 11,
      "target": 5
    },
    {
      "key": "58fb588aa8730d236338b4e9306fbd54",
      "relation": "partOf",
      "source": 11,
      "target": 8
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "da8cf796bbdcd3a75dee274045660f48",
      "line": 129,
      "relation": "decreases",
      "source": 11,
      "subject": {
        "modifier": "Activity"
      },
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Dose": {
          "80 nM": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "From these results, we conclude that LY294002 and wortmannin inhibit SARS pseudovirus entry by targeting PI4KB and that PI4KB is involved in SARS-CoV S-mediated entry into VeroE6 cells.",
      "key": "c5b234b0fc00aa32914be36f8b111bad",
      "line": 83,
      "relation": "decreases",
      "source": 6,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Dose": {
          "80 nM": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "From these results, we conclude that LY294002 and wortmannin inhibit SARS pseudovirus entry by targeting PI4KB and that PI4KB is involved in SARS-CoV S-mediated entry into VeroE6 cells.",
      "key": "1ac44edd2205e20e4c8c276b4c4be637",
      "line": 84,
      "relation": "decreases",
      "source": 5,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Protein_tag": {
          "FLAG-Sac1": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "As demonstrated by the virus entry assay (Fig. 3, A and B), SARS-CoV S-mediated entry was reduced by \u000480% in VeroE6 cells that transiently overexpressed recombinant FLAG-Sac1 compared with control VeroE6 cells, whereas VSV-G pseudovirus entry was not affected by recombinant Sac1 expression.",
      "key": "c944fd9eca401296c6c10b0763b22293",
      "line": 92,
      "relation": "decreases",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 12
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "These results indicate that PI4P is indispensable for SARSCoV S-mediated entry and suggest that PI4KB mediates SARS-CoV S entry by regulating the level of cellular PI4P.",
      "key": "88680fb0f528193d3f79999407393142",
      "line": 102,
      "relation": "increases",
      "source": 10,
      "target": 12
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Protein_tag": {
          "FLAG-Sac1": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "As demonstrated by the virus entry assay (Fig. 3, A and B), SARS-CoV S-mediated entry was reduced by \u000480% in VeroE6 cells that transiently overexpressed recombinant FLAG-Sac1 compared with control VeroE6 cells, whereas VSV-G pseudovirus entry was not affected by recombinant Sac1 expression.",
      "key": "21c2b3e65f8dd0b4099eb4990cded75b",
      "line": 94,
      "relation": "decreases",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 4
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "3a4b17e4d2947321c4de3a042cb0ba61",
      "line": 133,
      "relation": "decreases",
      "source": 10,
      "target": 4
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "These results indicate that PI4P is indispensable for SARSCoV S-mediated entry and suggest that PI4KB mediates SARS-CoV S entry by regulating the level of cellular PI4P.",
      "key": "1843e44e7790e03618fcb764c517e283",
      "line": 101,
      "relation": "regulates",
      "source": 10,
      "subject": {
        "effect": {
          "name": "cat",
          "namespace": "bel"
        },
        "modifier": "Activity"
      },
      "target": 0
    },
    {
      "annotations": {
        "CellLine": {
          "VERO C1008 cell": true
        },
        "Extract_type": {
          "Lipid": true
        },
        "Protein_tag": {
          "FLAG-Sac1": true
        },
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "Detection of PI4P from lipid extracts of VeroE6 cells that were transfected with FLAG-Sac1 or a control plasmid revealed that ectopic expression of Sac1 reduced the levels of PI4P in VeroE6 (Fig. 4, F and G). These results demonstrate that Sac1 phosphatase is a key factor in regulating PI4P levels in VeroE6 cells.",
      "key": "2d216fa4c9832b2d18e4e51cdda4dd52",
      "line": 118,
      "relation": "regulates",
      "source": 10,
      "target": 0
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "debb4093ae725c58d588b68e8771bdec",
      "line": 132,
      "relation": "decreases",
      "source": 10,
      "target": 0
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "9846ff015ac53d8957507b0bee401c88",
      "line": 125,
      "relation": "increases",
      "source": 7,
      "target": 2
    },
    {
      "key": "af79c896d7bc50ee51f44fdae49f7934",
      "relation": "partOf",
      "source": 9,
      "target": 7
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Published": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "authors": [
          "Deng J",
          "Jiang C",
          "Ju X",
          "Lang J",
          "Ma P",
          "Yang N",
          "Zhang G",
          "Zhang Y"
        ],
        "date": "2012-03-09",
        "db": "PubMed",
        "db_id": "22253445",
        "db_name": "The Journal of biological chemistry",
        "first": "Yang N",
        "last": "Jiang C",
        "pages": "8457-67",
        "volume": "287"
      },
      "evidence": "FIGURE 7. Model of the PI kinases and PI4P involved in SARS-CoV S-mediated entry. After SARS-CoV binds to ACE2, PI4P, the catalytic product of PI4KB, creates a lipid microenvironment or PI4P-enriched organelle required for the steps leading to fusion. Pharmacological inhibitors of PI4KB, such as LY294002 or wortmannin, suppress PI4KB activity and thereby inhibit SARSCoV S-mediated entry. Cellular factors, such as PI3Ks or Sac1, that negatively regulate PI4P generation can also inhibit SARS-CoV S-mediated entry.",
      "key": "d81a2cbdbdc932b1f4aeae6f7c87ca6c",
      "line": 126,
      "relation": "increases",
      "source": 8,
      "target": 2
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"phosphatidylinositol 4-phosphate\")",
      "concept": {
        "name": "phosphatidylinositol 4-phosphate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f289d25f2f8cb991476d3ed1c3a03457"
    },
    {
      "bel": "a(CHEBI:wortmannin)",
      "concept": {
        "name": "wortmannin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "abef9467f6c534de16db23b25da537c5"
    },
    {
      "bel": "a(GO:\"organelle-enclosing lipid monolayer\")",
      "concept": {
        "name": "organelle-enclosing lipid monolayer",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "8c4ee2bdf375673c372bd678acd84b35"
    },
    {
      "bel": "a(PUBCHEM:3973)",
      "concept": {
        "name": "3973",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "06e37dbfdc00f96435c89413d8f433e0"
    },
    {
      "bel": "a(TAX:\"Severe acute respiratory syndrome-related coronavirus\")",
      "concept": {
        "name": "Severe acute respiratory syndrome-related coronavirus",
        "namespace": "TAX"
      },
      "function": "Abundance",
      "id": "a824ba056422b4e42996cd3269ec9a19"
    },
    {
      "bel": "complex(a(CHEBI:wortmannin), p(UNIPROT:B1MTG7))",
      "function": "Complex",
      "id": "723e3692921ec499cdeaef2f21445ab9",
      "members": [
        {
          "bel": "a(CHEBI:wortmannin)",
          "concept": {
            "name": "wortmannin",
            "namespace": "CHEBI"
          },
          "function": "Abundance",
          "id": "abef9467f6c534de16db23b25da537c5"
        },
        {
          "bel": "p(UNIPROT:B1MTG7)",
          "concept": {
            "name": "B1MTG7",
            "namespace": "UNIPROT"
          },
          "function": "Protein",
          "id": "28e062644d1eb5cc45d45d5d3e1d8ac2"
        }
      ]
    },
    {
      "bel": "complex(a(PUBCHEM:3973), p(UNIPROT:B1MTG7))",
      "function": "Complex",
      "id": "eacf217473687d6a891e1283e7e1817a",
      "members": [
        {
          "bel": "a(PUBCHEM:3973)",
          "concept": {
            "name": "3973",
            "namespace": "PUBCHEM"
          },
          "function": "Abundance",
          "id": "06e37dbfdc00f96435c89413d8f433e0"
        },
        {
          "bel": "p(UNIPROT:B1MTG7)",
          "concept": {
            "name": "B1MTG7",
            "namespace": "UNIPROT"
          },
          "function": "Protein",
          "id": "28e062644d1eb5cc45d45d5d3e1d8ac2"
        }
      ]
    },
    {
      "bel": "complex(a(TAX:\"Severe acute respiratory syndrome-related coronavirus\"), p(UNIPROT:A0A0D9RQZ0))",
      "function": "Complex",
      "id": "862442cb17e18b25c66e2b904bb61ead",
      "members": [
        {
          "bel": "a(TAX:\"Severe acute respiratory syndrome-related coronavirus\")",
          "concept": {
            "name": "Severe acute respiratory syndrome-related coronavirus",
            "namespace": "TAX"
          },
          "function": "Abundance",
          "id": "a824ba056422b4e42996cd3269ec9a19"
        },
        {
          "bel": "p(UNIPROT:A0A0D9RQZ0)",
          "concept": {
            "name": "A0A0D9RQZ0",
            "namespace": "UNIPROT"
          },
          "function": "Protein",
          "id": "739508b2289934835fb174b9da81b196"
        }
      ]
    },
    {
      "bel": "complex(a(TAX:\"Severe acute respiratory syndrome-related coronavirus\"), p(UNIPROT:B1MTG7))",
      "function": "Complex",
      "id": "b2e7446e3bddba4ec1ceef4e3deac4c6",
      "members": [
        {
          "bel": "a(TAX:\"Severe acute respiratory syndrome-related coronavirus\")",
          "concept": {
            "name": "Severe acute respiratory syndrome-related coronavirus",
            "namespace": "TAX"
          },
          "function": "Abundance",
          "id": "a824ba056422b4e42996cd3269ec9a19"
        },
        {
          "bel": "p(UNIPROT:B1MTG7)",
          "concept": {
            "name": "B1MTG7",
            "namespace": "UNIPROT"
          },
          "function": "Protein",
          "id": "28e062644d1eb5cc45d45d5d3e1d8ac2"
        }
      ]
    },
    {
      "bel": "p(UNIPROT:A0A0D9RQZ0)",
      "concept": {
        "name": "A0A0D9RQZ0",
        "namespace": "UNIPROT"
      },
      "function": "Protein",
      "id": "739508b2289934835fb174b9da81b196"
    },
    {
      "bel": "p(UNIPROT:A0A0D9RUU7)",
      "concept": {
        "name": "A0A0D9RUU7",
        "namespace": "UNIPROT"
      },
      "function": "Protein",
      "id": "4df932d17010c72f9d78b49dc8c37899"
    },
    {
      "bel": "p(UNIPROT:B1MTG7)",
      "concept": {
        "name": "B1MTG7",
        "namespace": "UNIPROT"
      },
      "function": "Protein",
      "id": "28e062644d1eb5cc45d45d5d3e1d8ac2"
    },
    {
      "bel": "p(UNIPROT:P59594)",
      "concept": {
        "name": "P59594",
        "namespace": "UNIPROT"
      },
      "function": "Protein",
      "id": "7543d9372e2f08df7ae62ef5685b391b"
    }
  ]
}